MPR

FDA Restricts Use of Ingestible Fluoride Supplements for Children

Enforcement action will be taken against any company marketing the products for children under the age of 3 or who are at low or moderate risk for tooth decay.

Tylenol maker urges FDA to reject calls for autism warning label

Kenvue, the maker of Tylenol, is urging U.S. health regulators not to add an autism warning label to it and other ...

Tylenol maker: possible FDA label change ‘unsupported by scientific evidence’

Tylenol maker Kenvue is calling on the Food and Drug Administration (FDA) to back off a proposed safety label change to ...
CNN on MSN

Tylenol maker: FDA-backed label change ‘unsupported by scientific evidence’

Kenvue, the maker of Tylenol, opposes proposed changes to the product's safety label regarding potential links to autism and ...

The Number-One Red Flag On Store-Bought Food Labels Goes Far Beyond The Ingredients Themselves

Reading nutrition facts can be tough, especially when certain elements are unclear -- so keep this red flag in mind when ...
Opinion
STATOpinion

A sports device to ‘protect the brain’ illustrates a major problem with the FDA de novo pathway

This is not just about one device. It’s about what happens when institutions grow comfortable living in their own ambiguity and hiding behind opacity.” ...

Nationwide drug recall for popular muscle relaxer in effect: FDA

A popular muscle relaxer made in New Jersey is being recalled due to a label swap, according to the FDA. The product was ...

Tylenol manufacturer urges FDA to reject request against label change warning of link to autism

Kenvue, the American company that makes Tylenol, says the FDA should not make proposed changes to the drug's safety label ...
Opinion

Amarin Issues Statement Supporting FDA’s Action to Revise Labeling for Fenofibrate Drugs Reinforcing a Lack of Cardiovascular Benefit

Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular care worldwide, today issued the following statement in response to the recent action taken by the ...

FDA asked to update label on acetaminophen

A petition asks the FDA to change the label to better reflect research about a possible connection between acetaminophen use during pregnancy and autism.
Fierce Pharma

Merck nabs updated FDA label for soon-to-be-blockbuster Winrevair

More and more, as momentum builds for the soon-to-be-blockbuster Winrevair, Merck’s $11.5 billion buyout of Acceleron in 2021 is looking like a savvy move. | Paving the way for the label update were ...